AMPLIFY-7P, a first in human safety and efficacy trial of adjuvant mKRAS-specific lymph node-targeted Amphiphile ELI-002 7P vaccine in minimal residual disease positive pancreatic and colorectal cancer patients (ASCO 2024 – Scientific Poster)